On Wednesday, March 18th, Stephanie Schonewald will serve as both a moderator and presenter at the 2026 Peptide Drug Summit in Boston. At 11:00 a.m., Stephanie will moderate the panel discussion, “Developing Peptide Therapeutics: Technology-Enabled Design and Process Development Strategies,” which will address prioritizing peptides over other modalities, optimizing discovery workflows, integrating AI models with natural peptide data, engineering amino acid function, and streamlining complex peptide process development. At 5:00 p.m., Stephanie will present the session, “Designing Peptide Portfolios for Worldwide Success,” which will cover how to stage patent applications for peptide inventions and extend exclusivity, tailor claims for different jurisdictions, and anticipate how clinical trials affect the patentability of later-stage U.S. applications. learn more